First person enrolled in US study to assess efficacy of siltuximab as COVID-19 therapy,

Unlike previous clinical trials of agents targeting the interleukin-6 (IL-6) signaling pathway, EUSA Pharma said the ‘SILVAR’ study has been rationally …, Unlike previous clinical trials of agents targeting the interleukin-6 (IL-6) signaling pathway, EUSA Pharma said the ‘SILVAR’ study has been rationally …, Read More

Scroll to Top